Showing results (71-80 of 1,447) with videos related to

Sort By:
Pageof 145
Proteomics. Clinical Applications|December 17, 2019
Label-Free Quantitative Proteomics versus Antibody-Based Assays to Measure Neutrophil-Derived Enzymes in SalivaAngelika Silbereisen, Saeed Alassiri, Kai Bao, et al.
Proteomics. Clinical Applications|February 25, 2018
Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal CancerJuhura G Almazi, Peter Pockney, Craig Gedye, et al.
Proteomics. Clinical Applications|February 25, 2018
The Impact of Pre-Analytical Conditions on Human Serum Peptidome ProfilingAndrea Padoan
Proteomics. Clinical Applications|July 6, 2016
The intricacy of biomarker complexity-the identification of a genuine proteomic biomarker is more complicated than believedRita Büchler, Sindy Wendler, Petra Muckova, et al.
Proteomics. Clinical Applications|July 6, 2016
Cysteine redox proteomics of the hemoglobin-depleted cytosolic fraction of stored red blood cellsJulien Delobel, Michel Prudent, David Crettaz, et al.
Proteomics. Clinical Applications|July 7, 2016
Proteomics reveals reduced expression of transketolase in pyrimidine 5'-nucleotidase deficient patientsBenjamin A Barasa, Brigitte A van Oirschot, Paola Bianchi, et al.
Proteomics. Clinical Applications|November 10, 2018
Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and ImmunohistochemistryFranziska Hoffmann, Claudia Umbreit, Thomas Krüger, et al.
Proteomics. Clinical Applications|November 19, 2016
Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MSQiutao Meng, Siqi Ge, Wenhua Yan, et al.
Proteomics. Clinical Applications|November 19, 2016
Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individualsJingxin Wang, Robert Cunningham, Henrik Zetterberg, et al.
Proteomics. Clinical Applications|October 25, 2016
Pretreatment 14-3-3 epsilon level is predictive for advanced extranodal NK/T cell lymphoma therapeutic response to asparaginase-based chemotherapyYajuan Qiu, Zhiyuan Zhou, Zhaoming Li, et al.
Pageof 145